Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
11/2008
11/25/2008CA2322689C Substituted bisindolymaleimides for the inhibition of cell proliferation
11/25/2008CA2318579C Nitrogen-containing heterocyclic compounds and medicaments containing the compounds
11/25/2008CA2224369C Aromatic acid diamides with antigastrin activity, a method for their preparation and their pharmaceutical use
11/25/2008CA2211749C Biphenyl-substituted triazines as light stabilizer
11/20/2008WO2008141020A1 2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines and pyridines and 3-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-2-phenyl pyridines as 5-ht7 receptor antagonists
11/20/2008WO2008140895A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
11/20/2008WO2008140197A1 Novel carbamoyloxy aryl alkan arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
11/20/2008WO2008139941A1 Substituted imidazole compound and use thereof
11/20/2008WO2008139287A1 Azetidine derivatives and their use as prostaglandin e2 antagonists
11/20/2008WO2008139152A1 N-oxide-containing pharmaceutical compounds
11/20/2008WO2008138917A1 Novel aromatic heterocyclic carboxylic acid amide derivatives useful as potassium channel modulators
11/20/2008WO2008138615A1 Bicyclic and heterobicyclic derivatives, processes for preparing them and their uses
11/20/2008WO2008138448A2 Heterocyclic indazole derivatives
11/20/2008WO2008117079B1 Antimicrobial compounds based upon 4-aminoquinoline
11/20/2008WO2008111077A3 Self-assembled polyhedral multimeric chemical structures
11/20/2008WO2007110418A3 Substituted 5-hetaryl-4-aminopyrimidines
11/20/2008US20080287681 Substituted Benzimidazoles and their Use for Inducing Apoptosis
11/20/2008US20080287676 Fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
11/20/2008US20080287674 Inhibitors of Factor XA and Other Serine Proteases Involved in the Coagulation Cascade
11/20/2008US20080287504 Such as N-(4-Fluoro-benzyl)-4-(3-phenyl-indole-1-sulfonyl)-benzamide; Cannabinoid-1 (CB1) receptor; dietetics
11/20/2008US20080287475 4-(3-Aminopyrazole) Pyrimidine Derivatives for Use as Tyrosine Kinase Inhibitors in the Treatment of Cancer
11/20/2008US20080287460 New compounds 835
11/20/2008US20080287455 Sulfanyl substituted phenyl methanones
11/20/2008US20080287454 Cxcr4 antagonists
11/20/2008US20080287452 Heteroaryl/aryl pyrimidine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system
11/20/2008US20080287449 Aza-tripeptide hepatitis c serine protease inhibitors
11/20/2008US20080287444 Pyrazole compounds useful as protein kinase inhibitors
11/20/2008US20080287440 Novel Antifungal Triazole Derivatives
11/20/2008US20080287438 Agent for preventing or treating neuropathy
11/20/2008US20080287437 Pyrazolylaminopyrimidine Derivatives Useful as Tyrosine Kinase Inhibitors
11/20/2008US20080287431 Heterocyclic Compound and Anti-Malignant-Tumor Agent Containing the Same as Active Ingredient
11/20/2008US20080287427 Bicyclic Amides as Kinase Inhibitors
11/20/2008US20080287410 Pyrimidine derivatives useful as inhibitors of pkc-theta
11/20/2008US20080287390 Pyrazolidinol compounds
11/20/2008US20080286810 Use of Inhibtors of Glutaminyl Cyclases for Treatment and Prevention of Disease
11/20/2008US20080286607 4-(4-bromophenyl)-3,5-diphenyl-4H-1,2,4-triazole; high triplet excitation energy; high luminous efficiency, low power consumption
11/20/2008US20080284322 Nitrogenous Heterocyclic Derivative and Organic Electroluminescence Device Making Use of the Same
11/20/2008DE102007022565A1 Heterocyclische Indazolderivate Heterocyclic indazole derivatives
11/20/2008CA2687162A1 Heterocyclic indazole derivatives
11/20/2008CA2686547A1 Novel carbamoyloxy aryl alkan arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
11/20/2008CA2686517A1 Azetidine derivatives and their use as prostaglandin e2 antagonists
11/20/2008CA2684666A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
11/20/2008CA2684563A1 2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines and pyridines and 3-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-2-phenyl pyridines as 5-ht7 receptor antagonists
11/20/2008CA2667447A1 Mapk/erk kinase inhibitors
11/19/2008EP1992625A1 Arylamide pyrimidone compounds
11/19/2008EP1992624A1 Heteroarylamide pyrimidone compounds
11/19/2008EP1992623A1 Heteroaryl benzamide derivative for use as GLK activator in the treatment of diabetes
11/19/2008EP1992621A1 Heteroarylamide-substituted pyrimidone derivatives for the treatment of neurodegenerative diseases
11/19/2008EP1992618A1 Polycyclic cinnamide derivative
11/19/2008EP1991540A1 Cinnoline derivatives as phosphodiesterase 10 inhibitors
11/19/2008EP1991532A2 Compositions and methods for inhibition of the jak pathway
11/19/2008EP1991531A1 Cinnoline and quinoxaline derivates as phosphodiesterase 10 inhibitors
11/19/2008EP1991530A1 Cinnoline derivatives as phosphodiesterase 10 inhibitors
11/19/2008EP1991528A2 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
11/19/2008EP1991514A1 Novel anthracene derivative and organic electronic device using the same
11/19/2008EP1991229A2 Co-crystals and pharmaceutical compositions comprising the same
11/19/2008EP1753727B1 Novel cis-imidazolines
11/19/2008EP1751131B1 Mtp inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles
11/19/2008EP1594862B1 Methods of making 6-[ (4,5-dihydro-1h-imidazol-2-yl)amino-] -7-methyl-1h-benzimidazole-4-carbonitrile and its preferred salt form
11/19/2008EP1427326B1 Combination therapy for the treatment of cancer
11/19/2008CN101309906A 8-substituted benzoazepines as toll-like receptor modulators
11/19/2008CN101309905A Substituted isoindolones and their use as metabotropic glutamate receptor potentiators
11/19/2008CN101307047A Heterocyclic compounds and applications thereof as antineoplastic drugs
11/19/2008CN101307046A Tripeptidyl peptidase inhibitors
11/19/2008CN100435027C Organic light receptor with charge transfer compound for electronic photographing
11/19/2008CN100434425C 4-quinazolone derivative and its use in anti-tumor medicine
11/19/2008CN100434420C Compound inhibiting dipeptidyl peptidase iv
11/18/2008US7453002 Five-membered heterocycles useful as serine protease inhibitors
11/18/2008US7452997 Tetrahydro-indazole cannabinoid modulators
11/18/2008US7452913 Patterns of enzyme inhibitors formed by dissolving compounds and isolation by precipitation
11/18/2008US7452911 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
11/18/2008US7452907 Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method
11/18/2008US7452905 Phenylalanine derivatives
11/18/2008US7452897 Use of substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives for the treatment of neurodegenerative diseases
11/18/2008US7452890 Substituted pyrazoles
11/18/2008US7452886 E.g., 6-(6-Chloro-pyridin-3-yloxymethyl)-7-(2,2-dimethyl-propyl)-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile; in particular, cathepsin K inhibitors; osteoporosis; oral, autoimmune and respiratory diseases; osteoarthritis; antiarthritic and antitumor agents; muscular dystrophy; amytrophy; parasiticides
11/18/2008US7452885 Amino-5-(6-membered)heteroarylimidazolone compounds and the use thereof for β-secretase modulation
11/18/2008US7452882 Thyroid hormone analogs
11/18/2008US7452881 Such as N-[3-(2-diethylaminoethyl)-1H-indol-5-yl]-5-chloro-3-methylbenzo[b]thiophene-2-sulphonamide; serotonin receptors antagonist; anxiolytic, antidepressant, cognitive activator, senile dementia, psychosis, attention deficit/hyperactivity disorder
11/18/2008US7452879 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
11/18/2008US7452874 Thrombopoietin mimetics
11/18/2008US7452873 Inhibitors of GSK-3 and uses thereof
11/18/2008CA2422379C Pyrazole compounds useful as protein kinase inhibitors
11/18/2008CA2383630C Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
11/18/2008CA2331850C Method of preparing carboxylic acid derivatives and condensing agent comprising a quaternary ammonium salt
11/18/2008CA2278331C 3-heterocyclyl-substituted benzoyl derivatives
11/18/2008CA2230516C Pyrimidine derivatives
11/18/2008CA2124329C Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles
11/13/2008WO2008137622A2 Aminopyrimidines useful as kinase inhibitors
11/13/2008WO2008137621A1 Aminopyrimidines useful as kinase inhibitors
11/13/2008WO2008137134A2 Amorphous eletriptan hydrobromide and process for preparing it and other forms of eletriptan hydrobromide
11/13/2008WO2008137102A2 Methods of modulating amyloid beta and compounds useful therefor
11/13/2008WO2008137087A1 Processes for preparing (r)-2-methylpyrrolidine and (s)-2-methylpyrrolidine and tartrate salts thereof
11/13/2008WO2008135830A1 N- [6-amino-5- (phenyl) pyrazin-2-yl] -isoxazole-4-carboxamide derivatives and related compounds as nav1.8 channel modulators for the treatment of pain
11/13/2008WO2008135795A2 Polymorphic forms of bosentan
11/13/2008WO2008135591A1 Novel benzamidine derivatives useful as potassium channel modulators
11/13/2008WO2008135526A1 Carboxylic acid amides as factor xa inhibitors
11/13/2008WO2008115516A3 4'-o-substituted isoindoline derivatives and compositions comprising and methods of using the same
11/13/2008WO2008114023A3 Phthalazinone derivatives
11/13/2008WO2008097640A8 Triazole compounds that are useful in the treatment of proliferative disorders, such as cancer
1 ... 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 ... 626